Back
Renalytix PLC 10K Form
Sell
13
RNLX
Renalytix PLC
Last Price:
0.70
Seasonality Move:
-1.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RNLX News And Ratings
See the #1 stock for the next 7 days that we like better than RNLX
RNLX Financial Statistics
Sales & Book Value
| Annual Sales: | $3.4M |
|---|---|
| Cash Flow: | $-7.84M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.05 |
| Price / Book: | 13.12 |
Profitability
| EPS (TTM): | -0.90000 |
|---|---|
| Net Income (TTM): | $-42.5M |
| Gross Margin: | $720K |
| Return on Equity: | -604.93% |
| Return on Assets: | -149.1% |
Renalytix PLC Earnings Forecast
Key Renalytix PLC Financial Ratios
- The Gross Profit Margin over the past 5 years for RNLX is 21.16%.
- The Selling, General & Administrative Expenses for RNLX have been equal to 842.26% of Gross Profit Margin.
- The Research & Development expenses have been 420.16% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of RNLX is -1,340.20% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 2 years.
Renalytix PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | RNLX |
| Website: | renalytix.com |
Debt
| Debt-to-Equity Ratio: | 3.14 |
|---|---|
| Current Ratio: | 0.68 |
| Quick Ratio: | 0.59 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RNLX Technical Analysis vs Fundamental Analysis
Sell
13
Renalytix PLC (RNLX)
is a Sell
Is Renalytix PLC a Buy or a Sell?
-
Renalytix PLC stock is rated a Sell
The current Renalytix PLC [RNLX] share price is $0.70. The Score for RNLX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.